Lacosamide UCB
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lacosamide UCB, covering 2025-05-23 to 2026-08-20. Get the full timeline:
Most recent: EMA Authorised: Lacosamide UCB (lacosamide) — UCB Pharma S.A.